Impact of the time to start and end PD+HD combination on clinical outcomes in PD patients

Impact of the time to start and end PD+HD combination on clinical outcomes in PD patients - Clinical significance of PD+HD combination timing

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050421

Enrollment

200

Registered

2023-02-24

Start date

2021-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic renal failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who were treated with PD+HD for more than 1 month in the past and then changed to HD alone. 2) Dialysis solution Patients must use only glucose-neutral dialysate from the start of dialysis. Use of icodextrin dialysate is allowed. 3) PD+HD treatment method PD is limited to 5 or 6 days a week, and HD is limited to once a week. CAPD, APD, CCPD are all acceptable.

Exclusion criteria

Exclusion criteria: 1) Patients with cancer at the time of PD induction 2) Renal transplant patients under observation 3) Long-term (more than 6 hours) HD

Design outcomes

Primary

Measure	Time frame
1) Prognosis (survival, death) 2) Occurrence of complications (cardiovascular, malignancy, infection) requiring hospitalization	—

Countries

Japan

Contacts

Public ContactKei Nagai

Hitachi General Hospital Department of Nephrology

knagai@md.tsukuba.ac.jp+81-294-23-1111

Outcome results